Improvement of availability of allopurinol from pharmaceutical dosage forms I - Suppositories

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 49, Issue 2, 2000, Pages 119-127

  Samy, E M ^a   Hassan, M A ^a   Tous, S S ^a   Rhodes, C T ^b  

^a Assiut University   (Egypt)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Bioavailability studies; Crystallization; Solid dispersion; Suppositories

Indexed keywords

ALLOPURINOL; BETA CYCLODEXTRIN; DRUG CARRIER; MACROGOL; SALICYLATE SODIUM; UREA;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; INFRARED SPECTROSCOPY; MEMBRANE; NONHUMAN; RABBIT; SUPPOSITORY; X RAY POWDER DIFFRACTION;

ALLOPURINOL; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CYCLODEXTRINS; MALE; RABBITS; SODIUM SALICYLATE; SUPPOSITORIES; X-RAY DIFFRACTION;

EID: 0033995542     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(99)00079-X     Document Type: Article

References (27)

1. Chawla S.K., Patel H.D., Parrino G.R., Soterak J., Lopresti P.A., Dangelo W.A. Allopurinol hepatotoxicity. Case report and literature review. Arthritis Rheum. 20:1977;1546-1549.
2. Gilman A.G., Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 1980;720 Macmillan, New York.
3. Hussain A., Rytting J.G. Prodrug approach to enhancement of rate of dissolution of allopurinol. J. Pharm. Sci. 63:1976;798-799.
4. Appelbaum S.J., Mayersohn M., Dorr R.T., Perrier D. Allopurinol kinetics and bioavailability. Intravenous, oral and rectal administration. Cancer Chemother. Pharmacol. 8:1982;93-98.
5. Change S.L., Kramer W.G., Feldman S., Ballentine R., Frankel L.S. Bioavailability of allopurinol oral and rectal dosage forms (3 I0). Am. J. Hosp. Pharm. 38:1981;365-368.
6. V.S. Patel, PhD Thesis, University of Houston, Houston, TX, 1984.
7. Patel V.S., Kramer W.G. Allopurinol absorption from different sites of the rat gastrointestinal tract. J. Pharm. Sci. 75:(3):1981;275-277.
8. Chow K.Y., Go J., Grant D.J.W. Influence of fatty acid additives on the dissolution behavior of adipic acid crystals. Drug Dev. Ind. Pharm. 12:1986;247-257.
9. Najib N.M., Suleiman M., Malakh A. Characteristics of the in vitro release of ibuprofen from polyvinylpyrrolidone solid dispersions. Int. J. Pharm. 32:1986;229-236.
10. S.S. Tous, S.I. Abdel-Rahman, A.M. El-Sayed, Effect of formulation variables on the release behavior of allopurinol from suppositories. 5th Int. Conf. on Pharm. Tech. APG, 31 May, 1989, pp. 134-139.
11. Reynolds E.F. 'The Extra Pharmacopoeia' Martindale, 30th ed. 1993;333 The Pharmaceutical Press, London.
12. Othman S., Muti H. The effect of bases and formulation on the release of indomethacin from suppositories. Drug Dev. Ind. Pharm. 12:1986;1813-1831.
13. Fellstrom B., Backman U., Danielson B.G., Holgren K., Johansson G., Lindsjo M., Ljunghall S., Wikstrom B. Allopurinol treatment of renal calcium stone disease. Br. J. Urol. 57:1985;375-375.
14. W. Caraway, Int. Stand. Method. Clin. Chem., 4 (1963) 239, in: Uric acid Kit Pamphlet, BioMérieux, Laboratory Reagents and Products, France.
15. Hamza Y.E., Kota M. Improvement of dissolution characteristics and solubility of allopurinol via solid dispersion and hydrotropy with gentisic acid ethanolamide. Pharm. Ind. 52:(3):1990;363-368.
16. Giampiero B., Andrea G., Ferdinando G., Maria E.S. Thermal properties and mechanical stress of β-cyclodextrin. Eur. J. Pharm. Biopharm. 40:(4):1994;209-212.
17. Kurozurmi M., Nambu N., Nagai T. Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with α and β-cyclodextrins in powdered form. Chem. Pharm. Bull. 23:1975;3062-3068.
18. Yaginuma H., Isoda Y., Wada Y., Itoh S., Yamazaki M., Kamada A., Shimazu H., Makita I. Rectal delivery of antiinflammatory drugs. III. Effect of basic aminoacid salts of diclofenac sodium on the rectal absorption of ampicillin sodium. Chem. Pharm. Bull. 30:1982;1073-1076.
19. Murakami T., Yata N., Tamauchi H., Nakai J., Yamazaki M., Kamada A. Studies on absorption promoters for rectal delivery preparations. I. Promoting efficacy of enamine derivatives of amino acids for the rectal absorption of β-lactam antibiotics in rabbits. Chem. Pharm. Bull. 29:1981;1998-2004.
20. Hammouda Y.E., Kasim N.A., Nada A.H. Formulation and in vitro evaluation of verapamil HCl suppositories. Int. J. Pharm. 89:1993;111-118.
21. Chiou W.L., Chen S.J., Athanihar N. Enhancement of dissolution rates of poorly-water soluble drugs by crystallization in aqueous surfactant solutions. I. Sulfathiazole, prednisone and chloramphenicol. J. Pharm. Sci. 65:1976;1702-1705.
22. Frijlink H.W., Eissens A.C., Schoonen A.J.M., Lerk C.F. The effects of cyclodextrins on drug release from fatty suppository bases. I. In vitro observations. Eur. J. Pharm. Biopharm. 37:1991;178-182.
23. Frijlink H.W., Eissens A.C., Schoonen A.J.M., Lerk C.F. The effects of cyclodextrins on drug release from fatty suppository bases. II. In vivo observations. Eur. J. Pharm. Biopharm. 37:1991;183-187.
24. Uekama K., Imai T., Maeda T., Irie T., Hirayama F., Otagiri M. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis (2,6-di-O-methyl)-β-cyclodextrin. J. Pharm. Sci. 74:(8):1985;841-845.
25. Iwaoku R., Arimori K., Nakano M., Uekama K. Enhanced absorption of phenobarbital from suppositories containing phenobarbital-β-cyclodextrin inclusion complex. Chem. Pharm. Bull. 30:(4):1982;1416-1421.
26. Matsumoto Y., Watanabe Y., Tojina T., Murakosh R., Murakami C., Matsumato M. Rectal absorption enhancement of gentamicin in rabbits from hollow type suppositories by sodium salicylate or sodium caprylate (AD9). Drug Des. Deliv. 4:(3):1989;247-256.
27. Hosny E., El-Ahmady O., El-Shataway H., Nabih M., El-Damacy H., Gamel El-Deen S., El-Kabbany N. Effect of sodium salicylate on inclusion rectal absorption in humans. Arzneimittlel-Forschung. 44:(5):1994;611-613.